Skip to main content
. 2019 Apr 30;39(4):BSR20190447. doi: 10.1042/BSR20190447

Figure 4. The molecular mechanism of LOXL1-AS1 in osteosarcoma.

Figure 4

Knockdown of LOXL1-AS1 significantly inhibited p-PI3K and p-AKT expression but had no effect on PI3K and AKT expression in osteosarcoma cells.